Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cytotec (misoprostol 200 mcg uses price)?Razadyne generic name?Are you satisfied with lipitor's impact on your daily energy?Butorphanol tartrate?Genotropin cost per year?
See the DrugPatentWatch profile for Sugammadex
Sugammadex (Bridion) received European Medicines Agency (EMA) marketing authorization on 29 April 2009 [1].
You can verify the EMA authorization date in DrugPatentWatch’s drug record for sugammadex, which also tracks related regulatory and exclusivity/patent information [1].
The EMA approval date refers to the initial centralized marketing authorization granted by the European Commission for the product after EMA evaluation. Later changes (such as new indications or label updates) can occur after 2009, but the EMA’s original approval date for sugammadex is 29 April 2009 [1].
[1] https://www.drugpatentwatch.com/patent/bridion-sugammadex/
Other Questions About Sugammadex :